| Schedule of Computation of Basic and Diluted loss per share |
| |
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
| |
|
September 30,
|
|
|
September 30,
|
|
| |
|
2012
|
|
|
2011
|
|
|
2012
|
|
|
2011
|
|
| |
|
(unaudited)
|
|
|
(unaudited)
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for basic and diluted loss per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share -basic and diluted
|
|
$ |
(1,398,010 |
) |
|
$ |
(646,660 |
) |
|
$ |
(3,524,461 |
) |
|
$ |
(1,461,921 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic and diluted loss per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares Outstanding
|
|
|
4,298,150 |
|
|
|
3,203,346 |
|
|
|
4,077,600 |
|
|
|
2,657,202 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per common share
|
|
$ |
(0.33 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.86 |
) |
|
$ |
(0.55 |
) |
|
| Schedule of Anti-Delutive Effect |
| |
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
| |
|
September 30,
|
|
|
September 30,
|
|
| |
|
2012
|
|
|
2011
|
|
|
2012
|
|
|
2011
|
|
| |
|
(unaudited)
|
|
|
(unaudited)
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants
|
|
|
3,811,119 |
|
|
|
2,492,861 |
|
|
|
3,811,119 |
|
|
|
2,492,861 |
|
|
Stock options
|
|
|
1,840,556 |
|
|
|
787,778 |
|
|
|
1,840,556 |
|
|
|
787,778 |
|
|
Convertible notes
|
|
|
2,304,478 |
|
|
|
1,438,497 |
|
|
|
2,304,478 |
|
|
|
1,438,497 |
|
|
Series A Preferred
|
|
|
1,292,492 |
|
|
|
1,396,742 |
|
|
|
1,292,492 |
|
|
|
1,396,742 |
|
|
Series B Preferred
|
|
|
2,993,504 |
|
|
|
3,051,884 |
|
|
|
2,993,504 |
|
|
|
3,051,884 |
|
|
Series C Preferred
|
|
|
451,750 |
|
|
|
451,750 |
|
|
|
451,750 |
|
|
|
451,750 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
12,693,899 |
|
|
|
9,619,512 |
|
|
|
12,693,899 |
|
|
|
9,619,512 |
|
|